Matt Hancock discusses possible coronavirus vaccine passports
Covid vaccines have been handed out to more than eight million people in the UK, since their launch at the start of December. Since then, two more types of vaccine have been approved for mass distribution across the country, with another two expected to arrive shortly.
Covid has killed more than 100,000 people in the UK, with thousands of deaths being reported every week.
While the number of new cases has started to drop across the country, the number of people testing positive for COVID-19 is still remarkably high.
The Government has urged everyone that’s eligible to get a Covid vaccine.
Simply wait your turn, and the NHS will contact you to arrange an appointment for your first dose.
Express.co.uk compares all five of the Covid vaccines, including two that aren’t far away from entering into circulation.
We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
Pfizer/BioNTech
Type of vaccine: mRNA vaccine. It sends coded instructions to the immune system about how to produce antigens for the virus.
Effectiveness: 95 percent effective after both doses.
Approval: Approved for mass distribution in the UK, EU and US.
Delivery: UK ordered 40 million doses of the Pfizer vaccine. Pfizer expecting to make two billion doses for the world.
Location: Vaccines are made in Belgium, and are sent to the UK. Batches are then sent to various NHS trusts.
DON’T MISS
Covid new strain symptoms: Scientists discover fever temperature dips [LATEST]
Covid new strain symptoms warning: The ‘most unnoticeable’ sign [EXCLUSIVE]
Covid new strain symptoms: ONS discover top four signs [RESEARCH]
University of Oxford/AstraZeneca
Type of vaccine: Viral vector vaccine. Adapts a common cold virus to make it appear similar to the Covid virus.
Effectiveness: More than 90 percent effective after both doses.
Approval: Approved for mass distribution in the UK and EU.
Delivery: UK ordered 100 million doses of the Oxford vaccine. AstraZeneca expecting to make 25 million doses by the end of March.
Location: Manufacturing plants in Belgium and Germany, with others in the UK.
Moderna
Type of vaccine: mRNA vaccine. It sends coded instructions to the immune system about how to produce antigens for the virus.
Effectiveness: 94 percent effective after both doses.
Approval: Approved for mass distribution in the UK, EU and US.
Delivery: UK ordered 17 million doses of the Moderna vaccine, with first doses arriving in March.
Location: Moderna is a US-based company, with manufacturing plants in Switzerland and the US.
Novavax
Type of vaccine: Protein subunit vaccine. It contains coded messages from moth cells that boosts immune response.
Effectiveness: 89 percent effective after both doses.
Approval: Phase III trials concluded, but not yet approved for mass distribution.
Delivery: UK ordered 60 million doses of the Novavax vaccine.
Location: If it’s approved, the vaccine will be manufactured in the UK.
Johnson & Johnson
Type of vaccine: Viral vector vaccine. Adapts a common cold virus to make it appear similar to the Covid virus.
Effectiveness: 85 percent effective against serious disease after a single dose.
Approval: Phase III trials concluded, but not yet approved for mass distribution.
Delivery: UK ordered 30 million doses of the Johnson & Johnson vaccine.
Location: If it’s approved, the vaccine will be manufactured in the US.
Source: Read Full Article